| Product | Code | ||
|---|---|---|---|
| 16,17-Dihydroapovincamine | TN2642 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Metazin | T20796 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| A 56234 | T29498 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| 7,4-Di-O-methylapigenin 5-O-glucoside | TN3212 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Y1 receptor antagonist 1 | T12155 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| 4,6-Diisopropyl-m-cresol | T29427 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Chlortetracycline | T21081 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| (2-Aminoethyl)phosphinic acid | TN2749 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| MAL-di-EG-Val-Cit-PAB-MMAE | T18250 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Avizafone | T25121 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| PBP10 | TP1948 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| DJ-V-159 | T5100 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| UCM 454 | T34982 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Etofenprox | T20658 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Nifedipine | T1146 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| AMZ30 | T5182 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Unedone | TN5203 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Pulsatilla saponin D | T3909 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| 2-(Acetyloxy)-3-Methylbenzoic Acid | T0238 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| BIBX 1382 Dihydrochloride | T30443 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Tris(4-aminophenyl)methane | T19073 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| AM-2159 | T29935 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Lasiodin | TN1854 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| [Orn5]-URP acetate | TP1928L1 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
| Ligustroside | TN1871 | 1mg/5mg/10mg/25mg/50mg/100mg |
Contact us |
Hansa BioMed
HansaBioMed: leader in exosome based solutions for Life Sciences HansaBioMed OU is an innovative Company performing research and development in the field of Exosome Sciences. Its mission is to consolidate and maintain the worldwide leadership in production and commercialization of kits, reagents, equipment and services dedicated to exosome research for the Life Science market. HansaBioMed develops, produces and commercializes a wide range of products dedicated to the expanding market of exosome research, which are essential tools for all scientists engaged in this rapidly growing field of science. The best known of HansaBioMed owned brands is the ExoTESTTMplatform, a proprietary immune-based solution to capture, quantify and characterize exosomes from biological fluids.
More information? Contact Us by e-mail info@divbio.fr